Under Triage and Anticoagulants in the Geriatric Trauma Population Fragile Must be Italian. Barry McKenzie, MD St. Vincent Healthcare

Similar documents
Adult Reversal of Anticoagulation and Anti-platelet Agents for Life- Threatening Bleeding or Emergency Surgery Protocol

Guideline for Treatment of Head Injury in the Anticoagulated Patient

Geriatric Trauma Resuscitation: Lessons from a Geriatric Trauma Surgeon

Updates in Anticoagulation for Atrial Fibrillation and Venous Thromboembolism

Advances in Anticoagulation

Antiplatelets and Anticoagulants. Helen Leung, PharmD PGY1 Pharmacy Resident Memorial Hermann-Texas Medical Center

Anticoagulation Task Force

Financial Disclosure. Objectives 9/24/2018

High Risk + Challenging Trauma Cases. Hawaii. Topics 1/27/2014. David Thompson, MD, MPH. Head injury in the anticoagulated patient.

Update on Oral Anticoagulants. Dr. Miten R. Patel Cancer Specialists of North Florida Cell

ADMINISTRATIVE CLINICAL Page 1 of 6

The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center

Anticoagulation Management Around Endoscopy: GI Perspective. Nathan Landesman, DO FACOI Flint Gastroenterology Associates October 11, 2017

Trauma Alert Step 2 Additions

UPDATE OF NEUROCRITICAL CARE PHARMACOTHERAPY. Vera Wilson, PharmD, BCPS Emergency Services Clinical Pharmacy Specialist Johnson City Medical Center

Everything Your Pharmacist Wished You Knew About Anticoagulant Reversal Darrel W. Hughes, Pharm.D., BCPS University Health System & UT Health Science

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

Intracranial Hemorrhage. Objectives. What Do Need to Know?

Dr Micheal Looney Consultant Anaesthetist Connolly Hospital Blanchardstown. To Delay or Not to Delay Hip Fracture Surgery

Afib, Stroke, and DOAC. Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS

The INR: No Need Anymore? Daniel Blanchard, MD Professor of Medicine Director, Cardiology Fellowship Program UCSD Sulpizio Cardiovascular Center

Reversal Agents for Anticoagulants Understanding the Options. Katisha Vance, MD, FACP Alabama Oncology January 28, 2017

Professional Practice Minutes December 7, 2016

Introduction. Blood Pressure

Direct Oral Anticoagulants An Update

Treatment with Rivaroxaban Xarelto

Multidisciplinary Geriatric Trauma Care Guideline

Treatment with Apixaban Eliquis

Anticoagulants: Agents, Pharmacology and Reversal

Emergent Anticoagulation Reversal

Prothrombin Complex Concentrate- Octaplex. Octaplex

Reversal of Novel Oral Anticoagulants. Angelina The, MD March 22, 2016

UW MEDICINE PATIENT EDUCATION. Treating Blood Clots. What is a blood clot? DRAFT

Guidelines for the Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults

Lovenox to xarelto The Borg System is 100 % Retrievable & Reusable Lovenox to xarelto

Bleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM

INR as a Biomarker: Anticoagulation in Atrial Fib, Heart Failure, and Cardiovascular Disease Daniel Blanchard, MD, FACC, FAHA

ALL BLEEDING STOPS EVENTUALLY! PATRICK C. CULLINAN, DO FCCM, FACOI, FACOEP SAN ANTONIO, TX

Coagulation, Haemostasis and interpretation of Coagulation tests

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

About Blood Clots and How to Treat Them

Chapter 1 The Reversing Agents

Challenging Anticoagulation Case Studies. Earl J. Hope, M.D. Tower Health Cardiology

Chapter 1 Introduction

True/False: Idarucizumab can be utilized for the management of bleeding associated with dabigatran.

Oral Anticoagulants Update. Elizabeth Renner, PharmD, BCPS, BCACP, CACP Outpatient Cardiology and Anticoagulation

ADVOCATE HEALTHCARE GUIDELINE FOR ANTITHROMBOTIC REVERSAL

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient

Global Anticoagulants Market: Size, Trends & Forecasts ( ) April 2017

VENOUS THROMBOEMBOLISM PHARMACOLOGY. University of Hawai i Hilo DNP Program NURS 603 Advanced Clinical Pharmacology Danita Narciso Pharm D

THROMBOTIC DISORDERS: The Final Frontier

Use of Anticoagulant Reversal Agents

Hit head, on blood thinner-wife wants CT. Will Davies June 2014

Reducing the Use of Reversal Agents in a Community Hospital

Geriatric (Orthopaedic) Trauma

Individualizing VTE Treatment and Prevention of Recurrence: The Place for Direct Oral Anticoagulants in VTE

Goals. Geriatric Trauma. What s the impact Erlanger Trauma Symposium

Discuss the role of idarucizumab for the management of bleeding associated with dabigatran

Challenges in Coagulation

Hot Topics: Transitions of Care

Oral Factor Xa Inhibitors and Clinical Laboratory Monitoring

NEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS

Content 1. Relevance 2. Principles 3. Manangement

Leading the Charge in Anticoagulation Reversal: Benefits, Risks, and Key Factors in Application to the Traumatically Injured Patient

ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS

KCS Congress: Impact through collaboration

Aspirin versus pradaxa

ANTICOAGULANTS AND HIP FRACTURE SURGERY. Jon Antrobus Anaesthetist Borders General Hospital

Anticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT

Updates in Atrial Fibrillation

Emergency Management of Patients on Direct Oral Anticoagulants (DOACs)

Oral Anticoagulation Drug Class Prior Authorization Protocol

Plavix eliquis and aspirin

Appendix 3 PCC Warfarin Reversal

Mabel Labrada, MD Miami VA Medical Center

Nanik Hatsakorzian Pharm.D/MPH

Ischemic and hemorrhagic strokes in the context of the direct acting oral anticoagulants

Treatments for stroke prevention in Atrial Fibrillation as recommended by the Canadian Cardiovascular Society

Post-procedure dose ok after hours. 12 hours (q 24h dosing only) assuming surgical hemostasis; second dose 24 hours after first dose.

Managing Perioperative Anticoagulation. Edie Shen MD

a. A pharmacist may order a baseline SCr per protocol

This quiz is being published on behalf of the Education Committee of the SNACC.

Clinical issues which drug for which patient

Pros and Cons of Individual Agents Based on Large Trial Results: RELY, ROCKET, ARISTOTLE, AVERROES

A Cascade of Updates: Hot Topics in Anticoagulation

Prostate Biopsy Alerts

A VENOUS THROMBOEMBOLISM (VTE) TOWN HALL: Answering Your Top Questions on Treatment and Secondary Prevention

Saman Arbabi M.D., M.P.H., F.A.C.S. Kathleen O'Connell M.D. Bryce Robinson M.D., M.S., F.A.C.S., F.C.C.M

Razvana Akbar Anticoagulation Pharmacist LTH

Hemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures

Disclosure / Conflict of Interest. None

Head injury in children

Razvana Akbar Anticoagulation Pharmacist LTH

New Anticoagulants Therapies

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015

Boehringer-Ingelheim satellite symposium Ligue cardiologique belge 13/05/2017

Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture

The effect of the direct oral anticoagulants (DOACs) on haemostasis tests.

Disclosures. Learning Objectives. Financial: none. Off label discussion: Recommendations in lieu of data

Transcription:

Under Triage and Anticoagulants in the Geriatric Trauma Population Fragile Must be Italian Barry McKenzie, MD St. Vincent Healthcare

Objectives Describe the increasing frequency of trauma patients being elderly. Understand the consequences of under activation in the geriatric trauma patient. Describe some of the challenges in identifying a geriatric trauma patient. Discuss the various forms of common oral anticoagulants. Review existing means and agents for reversal of common anticoagulants.

Data What is geriatric? Age - 55? 65? 70? 80? EAST guidelines For all ISS and body region injured Age 45 55 Sharp increase in mortality Age 75 Doubled mortality

Data 10 14 % of all traumas victims are > 65 33% of all trauma care costs are spent on elderly patients Trauma care costs 3 times as much for an elderly person compared to a younger person Undertriage of the elderly two-fold increase in risk of death

Issues with Geriatric Trauma Increased morbidity and mortality across all injuries They are old why try? Many will return to pre-injury status with appropriate management Functional status becomes critical outcome measure Presenting GCS

Who is a Trauma? 69 year old female struck by a vehicle in Costco parking lot. She has GCS of 13 and left chest pain. 92 year old male who fell and struck her night stand going to the bathroom at night. He now has headache and hip pain. 76 year old female tripped while walking and struck her chin. Now with bilateral upper extremity paresthesia. 67 year old male farmer fell out of his tractor. He is mad because he got started late due to the local Coumadin clinic running behind.

Issues with Identifying Geriatric Trauma Patients Elderly normal physiology Chest and pulmonary function Neurological baseline Anticoagulants

Blood Pressure

Chest Injuries Bulger et al. Geriatric trauma patients and chest wall injuries 3-4 rib fractures Pneumonia increase 31% Mortality 19% More than 6 rib fractures 33% mortality 51% occurrence of pneumonia For each additional rib fracture Mortality increased by 19% Risks of pneumonia increased by 27%

Neurological Status Alteration in mental status Delirium Dementia Traumatic Brain Injury Organ failure leading to decreased organ perfusion Shock Quick escalation of injury due to anticoagulation Less endurance Airway management

GCS and Mortality

Under Triage JACS 2013 - Stanford University study 6,015 patients Age 55 and older Called 911 and admitted to hospital Records reviewed Mortality rates Trauma center 5.7% Nontrauma center 9% 32.8% met criteria for referral to trauma center (ISS > 15) Less procedures performed at nontrauma centers 1 day less in the trauma center

Ohio Geriatric Trauma Triage > 70 years old considered geriatric trauma patient GCS < 15 with evidence of traumatic brain injury Systolic BP < 100 mmhg Falls with evidence of TBI (even from standing height) Pedestrian struck by motor vehicle Multiple body regions injury Known or suspected proximal long bone fracture in MVC

Montana Geriatric Activation GCS < or equal to 13 with known/suspected TBI Decreased LOC Unequal pupils Persistent headache Blurred vision Nausea or vomiting Change in neurological status Systolic BP <110 mmhg or absent radial/carotid pulse Known/suspected proximal long bone fx with hx of MVC Multiple body regions injured Auto vs pedestrian Fall from any height with evidence of TBI Co-morbidities Anticoagulation agents

Scary News Over 6 million people on anticoagulants US population 326 million 30 million warfarin prescriptions written annually Over 2/3 of Medicare patients with atrial fibrillation are on warfarin Once anticoagulants start they stay

Anti-coagulation and Trauma Alert Protocol Triage parameters Age > or equal to 65 Anticoagulation agents GCS < or equal to 13 Hx of head within past 24 hours Response protocol ED response team (Provider, RN and lab) 15 minutes Coagulation lab tests and INR completed within 20 minutes Stat/priority head CT completed within 30 minutes

Anticoagulants Vitamin K antagonists Warfarin Antiplatelet agents Clopidogrel (Plavix) ASA Direct oral thrombin inhibitors Dabigatran (Pradaxa) Direct oral factor Xa inhibitors Apixaban (Eliquis) Ribaroxaban (Xarelto) Edoxaban (Savaysa) Indirect factor Xa inhibitors Fondaparinux (Arixtra)

Coumadin Inhibits Vitamin K dependent clotting factors II, VII, X Protein C & S Affects extrinsic & common pathways

Coumadin Reversal Vitamin K Four factor prothrombin complex concentrates (PCC) Rapid reversal of vitamin K antagonists Plasma derived products Kcentra, CSL Behring Expensive (single dose of Kcentra for 80 kg patient - $5,080) Effects can wear off Fresh frozen plasma

Plavix (clopidogrel) Inhibits function of ADP associated with platelet activation Most literature associated with ICH Platelets transfusion Desmopressin (DDAVP; promotes VWF as well as Factor VIII) Some discussion of steroids No great answer

Direct Thrombin Inhibitors Dabigatran (Pradaxa) Direct inhibitor of thrombin Prevents conversion of fibrinogen to fibrin Reversal Idarucizumab (Praxbind) Monoclonal antibody Binds to drug $3,000 to $4,000

Factor Xa Factor Xa is central to the propagation of coagulation In combination with cofactors bound to activated platelets, Factor Xa amplifies coagulation by converting prothrombin to thrombin

Factor Xa Inhibitors Direct Factor Xa inhibitor Rivaroxaban (Xarelto) Apixaban (Eliquis) Edoxaban (Savaysa) Indirect Factor Xa inhibitor Binds antithrombin - accelerates its inhibition of factor Xa. Fondaparinux (Arixtra)

Factor Xa inhibitors Reversal agent for Xarelto and Eliquis Andexxa FDA approval May 2018 Low and high dose regiment $25,000 to $50,000 projected figures for cost of treatment Drug cost only administration cost to patient? Only in 10 to 20 institutions throughout the US

Local challenges

Who is a Trauma? 69 year old female struck by a vehicle in Costco parking lot. She has GCS of 13 and left chest pain. 92 year old male who fell and struck her night stand going to the bathroom at night. He now has headache and hip pain. 76 year old female tripped while walking and struck her chin. Now with bilateral upper extremity paresthesia. 67 year old male farmer fell out of his tractor. He is mad because he got started late due to the local Coumadin clinic running behind.

Summary The geriatric population is becoming more and more the trauma population. Identifying the geriatric trauma patient requiring trauma activation can be difficult and likely requires separate activation criteria. Under activation of the geriatric trauma patient is a growing issue and has a negative effect on outcome. A growing number of patients are on some form anti coagulation and trauma providers need to be familiar with the various agents. Reversal agents for new anti coagulants exist but can be expensive and create a resource utilization challenge. Open discussions need to happen regarding maintenance of anticoagulants after trauma event.

Questions?

References ACS TQIP Geriatric Trauma Management Guidelines Bulger EM, Arneson MA, Mock CN, Jurkovich GJ. Rib fractures in elderly. J Trauma. 2000;48:1040 7 ems.ohio.gov http://www.aoa.gov/aging_statistics http://www.aamft.org http://www.cdc.gov/ http://www.nhtsa.gov/ https://www.med.unc.edu Jacobs, Plaisier, Barie, Hammond, Holevar, Sinclair, Scalea and Wahl (EAST Practice Management Guidelines Work Group, Pracitice Management Guidelines of Geriatric Trauma: The EAST Practice Management Guidelines Work Group, J Trauma. 54(2):391-416, February 2003. Jürgen Koscielny and Edita Rutkauskaite, Rivaroxaban and Hemostasis in Emergency Care, Emergency Medicine International, vol. 2014, Article ID 935474, 9 pages, 2014. doi:10.1155/2014/935474 Meadow, Dierks, Williams and Zacko, The Emergent Reversal of Coagulopathies Encountered in Neurosurgery and Neurology: A technical note, CM&R Rapid Release, November 7, 2014 Staudenmayer, Hsia, Mann, Spain and Newgard, Triage of Elderly Trauma Patients: A Population-Based Perspective, Journal of the American College of Surgeons, 2013; 217 (4): 569